GlassScriptPhysician profile
David Wilson Bevans
NPI 1144292368
$4,378.40
in general payments reported to CMS, 2019-2025
31 companies · $342 in 2025
The $342 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $592 · 2020: $331 · 2021: $411 · 2022: $2,014 · 2023: $360 · 2024: $329 · 2025: $342.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,030.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,030.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Silk Road Medical, INC. | $1,469.64 | 2021-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Ethicon US, LLC | $1,102.04 | 2019-2025 | Echelon; Endopath, Echelon Endopath, Vistaseal |
| Abbvie INC. | $343.01 | 2023-2025 | Natrelle Saline-Filled Breast Implants, Strattice Reconstructive Tissue Matrix Bps |
| Intuitive Surgical, INC. | $188.97 | 2022-2023 | |
| Allergan, INC. | $150.68 | 2019-2022 | |
| Innocoll Pharmaceuticals Limited | $124.87 | 2021-2022 | |
| Becton, Dickinson and Company | $115.91 | 2022 | |
| Smith+Nephew, INC. | $107.24 | 2019-2021 | |
| Davol INC. | $101.89 | 2022-2023 | Progel Applicator Spray Tips |
| Takeda Pharmaceuticals U.S.A., INC. | $88.97 | 2021-2023 | Gattex |
| Solventum Corporation | $86.74 | 2024-2025 | V.A.C. Veraflo Cleanse Choice, Prevena, V.A.C.Ulta |
| Kci USA, INC. | $78.91 | 2019-2023 | Prevena, V.A.C. Veraflo Cleanse Choice |
| Polynovo North America LLC | $69.18 | 2024-2025 | Novosorb Btm |
| Molnlycke Health Care US, LLC | $60.02 | 2022 | |
| Merck Sharp & Dohme LLC | $35.56 | 2019 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acera Surgical, INC. | $28.68 | 2019-2020 | |
| Endologix LLC | $23.24 | 2019 | |
| Kerecis Limited | $20.77 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Sanara Medtech INC. | $19.27 | 2025 | Celleraterx |
| Medtronic Vascular, INC. | $19.20 | 2020 | |
| W. L. Gore & Associates, INC. | $18.73 | 2022 | |
| Acell, INC. | $18.45 | 2020 | |
| Baudax Bio INC. | $17.36 | 2020 | |
| Boston Scientific Corporation | $16.36 | 2020 | |
| Kowa Pharmaceuticals America, INC. | $14.86 | 2023 | Seglentis |
| Medtronic, INC. | $13.98 | 2022 | |
| Covidien LP | $12.38 | 2020 | |
| Elutia, INC. | $11.69 | 2019 | |
| Stryker Corporation | $11.18 | 2019 | |
| Bolder Surgical LLC | $8.62 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$248,036.01 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Bevans listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.